Ernexa Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $31.5M
Liabilities Breakdown FY2021
Total Liabilities: $6.0M
Asset Breakdown
Total Assets: $31.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.0M | 53.9% |
| Accounts Receivable | $684.0K | 2.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $670.0K | 2.1% |
| Goodwill | $2.0M | 6.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $11.1M | 35.3% |
Liabilities Breakdown
Total Liabilities: $6.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.8M | 29.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.3M | 70.9% |